CHA2DS2-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
BackgroundUsing the CHA2DS2-VASc score to recognize the risk of stroke in patients with atrial fibrillation has been well-established. However, few studies have assessed whether the CHA2DS2-VASc score has a similar predictive value in recurrence after myocardial infarction (MI).MethodsWe conducted a...
Main Authors: | Hui Pang, Xu Zhu, Iokfai Cheang, Haifeng Zhang, Yanli Zhou, Shengen Liao, Xinli Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.925932/full |
Similar Items
-
Performance and validation of R-CHA2DS2VASc score for thromboembolism in patients with hypertrophic cardiomyopathy
by: Ziqiong Wang, et al.
Published: (2020-09-01) -
CHA2DS2‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
by: Eyal Nof, et al.
Published: (2020-01-01) -
Value of the CHA2DS2‐VASc score for predicting outcome in patients with heart failure
by: Mony Shuvy, et al.
Published: (2020-10-01) -
Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction
by: Çağrı Zorlu, et al.
Published: (2020-10-01) -
The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study
by: Alaa Quisi, et al.
Published: (2020-10-01)